OPKO HEALTH INC
(NYSE: OPK)

OPKO Health, Inc. (OPKO) is a multi-national biopharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, laboratory developed tests (LTDs), point-of-care tests and pharmaceuticals and vaccines. The Company operates in two segments: pharmaceutical and diagnostics. The pharmaceutical segment consists of two operating segments: pharmaceutical research and development segment which is focused on the research and development of pharmaceutical products and vaccines, and the pharmaceutical operations it acquired in Chile, Mexico, Israel, and Spain through acquisitions in those countries. Effective May 28, 2014, OPKO Health Inc acquired Inspiro Medical Ltd, a Misgav-based manufacturer and wholesaler of pharmaceuticals.

1.210

-0.040 (-3.20%)
价格区间 1.200 - 1.250   (4.17%)
开盘 1.245
昨收 1.250
6.550
买盘 -
6.560
卖盘 -
成交量 1,903,903
成交额 -
注释
数据延迟。最后一次更新13 Feb 2026 05:00.
数据提供商
查看所有活动

关于 OPKO HEALTH INC

OPKO Health, Inc. (OPKO) is a multi-national biopharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, laboratory developed tests (LTDs), point-of-care tests and pharmaceuticals and vaccines. The Company operates in two segments: pharmaceutical and diagnostics. The pharmaceutical segment consists of two operating segments: pharmaceutical research and development segment which is focused on the research and development of pharmaceutical products and vaccines, and the pharmaceutical operations it acquired in Chile, Mexico, Israel, and Spain through acquisitions in those countries. Effective May 28, 2014, OPKO Health Inc acquired Inspiro Medical Ltd, a Misgav-based manufacturer and wholesaler of pharmaceuticals.

Please login to view stock data and analysis